Odoribacter splanchnicus bacteremia: a rare condition associated with intestinal disease
Abstract
Odoribacter splanchnicus is an anaerobe that normally inhabits the human intestine and rarely causes infections in humans. In recent years, however, three cases of O. splanchnicus bacteremia have been reported. We retrospectively searched our laboratory information system and detected five cases of O. splanchnicus bacteremia in 2014-2024. All cases of O. splanchnicus bacteremia reported to date have been associated with intestinal infection, but our five cases included one associated with decubitus ulcer infection. Antimicrobial susceptibility testing results were available in four of our five cases. O. splanchnicus showed susceptibility to beta-lactams and metronidazole. However, one isolate was resistant to clindamycin, and another showed intermediate susceptibility to levofloxacin. Among our five cases and the three previously reported cases, no patient was using immunosuppressive agents or had immunocompromising diseases except for one case with malignancy. While O. splanchnicus bacteremia is certainly rare, more cases may be found by searching the laboratory information system as in this investigation. Further accumulation of cases will help to elucidate the pathogenesis of infections caused by O. splanchnicus, which is endemic in the gastrointestinal tract, and will reveal more information on antimicrobial susceptibility.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.